Rab35-regulated lipid turnover by myotubularins represses mTORC1 activity and controls myelin growth

[1]  A. Mégarbané,et al.  A multicenter retrospective study of charcot‐marie‐tooth disease type 4B (CMT4B) associated with mutations in myotubularin‐related proteins (MTMRs) , 2019, Annals of neurology.

[2]  Rongguang Zhang,et al.  Rab35/ACAP2 and Rab35/RUSC2 Complex Structures Reveal Molecular Basis for Effector Recognition by Rab35 GTPase. , 2019, Structure.

[3]  P. Pandolfi,et al.  The functions and regulation of the PTEN tumour suppressor: new modes and prospects , 2018, Nature Reviews Molecular Cell Biology.

[4]  B. Neumann,et al.  A RAB35-p85/PI3K axis controls oscillatory apical protrusions required for efficient chemotactic migration , 2018, Nature Communications.

[5]  U. Suter,et al.  Myelination and mTOR , 2017, Glia.

[6]  N. Pedersen,et al.  PtdIns3P controls mTORC1 signaling through lysosomal positioning , 2017, The Journal of cell biology.

[7]  D. Pareyson,et al.  New developments in Charcot–Marie–Tooth neuropathy and related diseases , 2017, Current opinion in neurology.

[8]  Jun Du,et al.  Folliculin Interacts with Rab35 to Regulate EGF-Induced EGFR Degradation , 2017, Front. Pharmacol..

[9]  U. Suter,et al.  Dual function of the PI3K-Akt-mTORC1 axis in myelination of the peripheral nervous system. , 2017 .

[10]  J. Milbrandt,et al.  mTORC1 promotes proliferation of immature Schwann cells and myelin growth of differentiated Schwann cells , 2017, Proceedings of the National Academy of Sciences.

[11]  A. Houdusse,et al.  Emerging roles of MICAL family proteins – from actin oxidation to membrane trafficking during cytokinesis , 2017, Journal of Cell Science.

[12]  Paul Beckett,et al.  Identification of apilimod as a first-in-class PIKfyve kinase inhibitor for treatment of B-cell non-Hodgkin lymphoma. , 2017, Blood.

[13]  A. Houdusse,et al.  Oxidation of F-actin controls the terminal steps of cytokinesis , 2017, Nature Communications.

[14]  C. Brombin,et al.  Niacin‐mediated Tace activation ameliorates CMT neuropathies with focal hypermyelination , 2016, EMBO molecular medicine.

[15]  A. Echard,et al.  Rab35 GTPase: A Central Regulator of Phosphoinositides and F‐actin in Endocytic Recycling and Beyond , 2016, Traffic.

[16]  J. Salzer,et al.  Akt Regulates Axon Wrapping and Myelin Sheath Thickness in the PNS , 2016, The Journal of Neuroscience.

[17]  A. Houdusse,et al.  Rab35 GTPase couples cell division with initiation of epithelial apico-basal polarity and lumen opening , 2016, Nature Communications.

[18]  M. Meisler,et al.  PI(3,5)P2 biosynthesis regulates oligodendrocyte differentiation by intrinsic and extrinsic mechanisms , 2016, eLife.

[19]  V. Haucke,et al.  Phosphatidylinositol 3‐phosphates—at the interface between cell signalling and membrane traffic , 2016, The EMBO journal.

[20]  V. Haucke,et al.  A phosphoinositide conversion mechanism for exit from endosomes , 2016, Nature.

[21]  D. Perrais,et al.  Rab35 GTPase Triggers Switch-like Recruitment of the Lowe Syndrome Lipid Phosphatase OCRL on Newborn Endosomes , 2016, Current Biology.

[22]  D. Sabatini,et al.  Identification of an oncogenic RAB protein , 2015, Science.

[23]  H. Sakagami,et al.  Arf6 mediates Schwann cell differentiation and myelination. , 2015, Biochemical and biophysical research communications.

[24]  Jean-Pierre Marquette,et al.  A highly potent and selective Vps34 inhibitor alters vesicle trafficking and autophagy. , 2014, Nature chemical biology.

[25]  S. Munro,et al.  Toward a Comprehensive Map of the Effectors of Rab GTPases , 2014, Developmental cell.

[26]  C. Wessig,et al.  mTORC1 controls PNS myelination along the mTORC1-RXRγ-SREBP-lipid biosynthesis axis in Schwann cells. , 2014, Cell reports.

[27]  Michael J. Munson,et al.  Characterization of VPS34-IN1, a selective inhibitor of Vps34, reveals that the phosphatidylinositol 3-phosphate-binding SGK3 protein kinase is a downstream target of class III phosphoinositide 3-kinase , 2014, The Biochemical journal.

[28]  A. Tanoue,et al.  Rab35, acting through ACAP2 switching off Arf6, negatively regulates oligodendrocyte differentiation and myelination , 2014, Molecular biology of the cell.

[29]  G. Tevzadze,et al.  Roles for PI(3,5)P2 in nutrient sensing through TORC1 , 2014, Molecular biology of the cell.

[30]  P. McPherson,et al.  Rab35: GEFs, GAPs and Effectors , 2013, Traffic.

[31]  P. McPherson,et al.  Interplay between Rab35 and Arf6 controls cargo recycling to coordinate cell adhesion and migration , 2013, Journal of Cell Science.

[32]  T. Blundell,et al.  Crystal structure of folliculin reveals a hidDENN function in genetically inherited renal cancer , 2012, Open Biology.

[33]  K. Inoki,et al.  Phosphatidylinositol 3,5-bisphosphate plays a role in the activation and subcellular localization of mechanistic target of rapamycin 1 , 2012, Molecular biology of the cell.

[34]  M. Fukuda,et al.  Rab35 regulates Arf6 activity through centaurin-β2 (ACAP2) during neurite outgrowth , 2012, Journal of Cell Science.

[35]  M. Groszer,et al.  Genetic disruption of Pten in a novel mouse model of tomaculous neuropathy , 2012, EMBO molecular medicine.

[36]  Brian Burke,et al.  A promiscuous biotin ligase fusion protein identifies proximal and interacting proteins in mammalian cells , 2012, The Journal of cell biology.

[37]  K. Nave,et al.  Arrest of Myelination and Reduced Axon Growth When Schwann Cells Lack mTOR , 2012, The Journal of Neuroscience.

[38]  B. Goud,et al.  An ARF6/Rab35 GTPase Cascade for Endocytic Recycling and Successful Cytokinesis , 2012, Current Biology.

[39]  P. McPherson,et al.  Connecdenn 3/DENND1C binds actin linking Rab35 activation to the actin cytoskeleton , 2012, Molecular biology of the cell.

[40]  N. Naslavsky,et al.  MICAL‐L1 is a Tubular Endosomal Membrane Hub that Connects Rab35 and Arf6 With Rab8a , 2012, Traffic.

[41]  M. Meisler,et al.  Genetic Interaction between MTMR2 and FIG4 Phospholipid Phosphatases Involved in Charcot-Marie-Tooth Neuropathies , 2011, PLoS genetics.

[42]  E. Formstecher,et al.  Rab35 GTPase and OCRL phosphatase remodel lipids and F-actin for successful cytokinesis , 2011, Nature Cell Biology.

[43]  P. Verstreken,et al.  Loss of Skywalker Reveals Synaptic Endosomes as Sorting Stations for Synaptic Vesicle Proteins , 2011, Cell.

[44]  W. Möbius,et al.  Regulation of exosome secretion by Rab35 and its GTPase-activating proteins TBC1D10A–C , 2010, The Journal of cell biology.

[45]  P. McPherson,et al.  The Connecdenn DENN domain: a GEF for Rab35 mediating cargo-specific exit from early endosomes. , 2010, Molecular cell.

[46]  M. Scott,et al.  Rab35 Controls Actin Bundling by Recruiting Fascin as an Effector Protein , 2009, Science.

[47]  A. Chishti,et al.  Dlg1, Sec8, and Mtmr2 Regulate Membrane Homeostasis in Schwann Cell Myelination , 2009, The Journal of Neuroscience.

[48]  J. Dixon,et al.  Loss of the inactive myotubularin-related phosphatase Mtmr13 leads to a Charcot–Marie–Tooth 4B2-like peripheral neuropathy in mice , 2008, Proceedings of the National Academy of Sciences.

[49]  C. Wessig,et al.  Mtmr13/Sbf2-deficient mice: an animal model for CMT4B2. , 2007, Human molecular genetics.

[50]  A. Quattrini,et al.  Charcot–Marie–Tooth type 4B demyelinating neuropathy: deciphering the role of MTMR phosphatases , 2007, Expert Reviews in Molecular Medicine.

[51]  U. Suter,et al.  Multi-level regulation of myotubularin-related protein-2 phosphatase activity by myotubularin-related protein-13/set-binding factor-2. , 2006, Human molecular genetics.

[52]  L. Wrabetz,et al.  Loss of Mtmr2 Phosphatase in Schwann Cells But Not in Motor Neurons Causes Charcot-Marie-Tooth Type 4B1 Neuropathy with Myelin Outfoldings , 2005, The Journal of Neuroscience.

[53]  J. Dixon,et al.  The Phosphoinositide-3-phosphatase MTMR2 Associates with MTMR13, a Membrane-associated Pseudophosphatase Also Mutated in Type 4B Charcot-Marie-Tooth Disease* , 2005, Journal of Biological Chemistry.

[54]  L. Wrabetz,et al.  Disruption of Mtmr2 produces CMT4B1-like neuropathy with myelin outfolding and impaired spermatogenesis , 2004, The Journal of cell biology.

[55]  R. Ravazzolo,et al.  Mutations in MTMR13, a new pseudophosphatase homologue of MTMR2 and Sbf1, in two families with an autosomal recessive demyelinating form of Charcot-Marie-Tooth disease associated with early-onset glaucoma. , 2003, American journal of human genetics.

[56]  K. Zerres,et al.  Mutation of the SBF2 gene, encoding a novel member of the myotubularin family, in Charcot-Marie-Tooth neuropathy type 4B2/11p15. , 2003, Human molecular genetics.

[57]  U. Suter,et al.  Loss of phosphatase activity in myotubularin-related protein 2 is associated with Charcot-Marie-Tooth disease type 4B1. , 2002, Human molecular genetics.

[58]  Soo-A Kim,et al.  Myotubularin and MTMR2, Phosphatidylinositol 3-Phosphatases Mutated in Myotubular Myopathy and Type 4B Charcot-Marie-Tooth Disease* , 2002, The Journal of Biological Chemistry.

[59]  Aldo Quattrone,et al.  Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2 , 2000, Nature Genetics.

[60]  L. Wrabetz,et al.  P0‐Cre Transgenic Mice for Inactivation of Adhesion Molecules in Schwann Cells , 1999, Annals of the New York Academy of Sciences.

[61]  C. Taveggia,et al.  DRG Neuron/Schwann Cells Myelinating Cocultures. , 2018, Methods in molecular biology.

[62]  S. Friant,et al.  WANTED - Dead or alive: Myotubularins, a large disease-associated protein family. , 2017, Advances in biological regulation.

[63]  S. Holm.  A Simple Sequentially Rejective Multiple Test Procedure , 1979 .

[64]  C. Wessig,et al.  mTORC 1 Controls PNS Myelination along the mTORC 1-RXR gamma-SREBP-Lipid Biosynthesis Axis in Schwann Cells , 2022 .